PROCTER & GAMBLE HEALTH | AARTI PHARMALABS | PROCTER & GAMBLE HEALTH/ AARTI PHARMALABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 36.8 | 23.8 | 154.6% | View Chart |
P/BV | x | 10.6 | 3.0 | 356.8% | View Chart |
Dividend Yield | % | 2.0 | 0.4 | 511.4% |
PROCTER & GAMBLE HEALTH AARTI PHARMALABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
AARTI PHARMALABS Mar-23 |
PROCTER & GAMBLE HEALTH/ AARTI PHARMALABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 397 | 1,351.5% | |
Low | Rs | 3,883 | 269 | 1,443.5% | |
Sales per share (Unadj.) | Rs | 740.7 | 214.6 | 345.1% | |
Earnings per share (Unadj.) | Rs | 138.2 | 21.3 | 647.5% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 28.3 | 549.2% | |
Dividends per share (Unadj.) | Rs | 95.00 | 2.00 | 4,750.0% | |
Avg Dividend yield | % | 2.1 | 0.6 | 342.1% | |
Book value per share (Unadj.) | Rs | 447.6 | 172.0 | 260.3% | |
Shares outstanding (eoy) | m | 16.60 | 90.63 | 18.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.6 | 402.4% | |
Avg P/E ratio | x | 33.5 | 15.6 | 214.5% | |
P/CF ratio (eoy) | x | 29.8 | 11.8 | 252.8% | |
Price / Book Value ratio | x | 10.3 | 1.9 | 533.5% | |
Dividend payout | % | 68.7 | 9.4 | 733.6% | |
Avg Mkt Cap | Rs m | 76,761 | 30,178 | 254.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 1,297 | 159.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 19,452 | 63.2% | |
Other income | Rs m | 184 | 23 | 793.4% | |
Total revenues | Rs m | 12,480 | 19,476 | 64.1% | |
Gross profit | Rs m | 3,247 | 3,421 | 94.9% | |
Depreciation | Rs m | 281 | 625 | 44.9% | |
Interest | Rs m | 8 | 211 | 3.7% | |
Profit before tax | Rs m | 3,142 | 2,608 | 120.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 673 | 125.9% | |
Profit after tax | Rs m | 2,295 | 1,935 | 118.6% | |
Gross profit margin | % | 26.4 | 17.6 | 150.2% | |
Effective tax rate | % | 27.0 | 25.8 | 104.5% | |
Net profit margin | % | 18.7 | 9.9 | 187.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 11,558 | 101.3% | |
Current liabilities | Rs m | 6,791 | 5,916 | 114.8% | |
Net working cap to sales | % | 40.0 | 29.0 | 138.0% | |
Current ratio | x | 1.7 | 2.0 | 88.3% | |
Inventory Days | Days | 263 | 16 | 1,635.3% | |
Debtors Days | Days | 343 | 826 | 41.6% | |
Net fixed assets | Rs m | 10,617 | 10,752 | 98.7% | |
Share capital | Rs m | 166 | 453 | 36.6% | |
"Free" reserves | Rs m | 7,265 | 15,132 | 48.0% | |
Net worth | Rs m | 7,431 | 15,585 | 47.7% | |
Long term debt | Rs m | 0 | 2 | 0.0% | |
Total assets | Rs m | 22,330 | 22,309 | 100.1% | |
Interest coverage | x | 409.1 | 13.4 | 3,055.6% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.9 | 63.2% | |
Return on assets | % | 10.3 | 9.6 | 107.2% | |
Return on equity | % | 30.9 | 12.4 | 248.7% | |
Return on capital | % | 42.4 | 18.1 | 234.4% | |
Exports to sales | % | 0 | 32.0 | 0.0% | |
Imports to sales | % | 13.1 | 10.1 | 129.6% | |
Exports (fob) | Rs m | NA | 6,231 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 1,959 | 81.9% | |
Fx inflow | Rs m | 1,465 | 6,231 | 23.5% | |
Fx outflow | Rs m | 1,605 | 2,061 | 77.9% | |
Net fx | Rs m | -140 | 4,171 | -3.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 2,630 | 89.7% | |
From Investments | Rs m | -215 | -1,578 | 13.6% | |
From Financial Activity | Rs m | -985 | -1,635 | 60.2% | |
Net Cashflow | Rs m | 1,160 | -583 | -199.1% |
Indian Promoters | % | 0.0 | 46.3 | - | |
Foreign collaborators | % | 51.8 | 0.2 | 30,482.4% | |
Indian inst/Mut Fund | % | 20.0 | 18.3 | 109.1% | |
FIIs | % | 6.2 | 8.3 | 74.9% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 53.5 | 90.0% | |
Shareholders | 56,778 | 204,122 | 27.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | AARTI PHARMALABS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.27% | -0.04% | 0.15% |
1-Month | -0.40% | 13.22% | 0.33% |
1-Year | 1.04% | 30.30% | 54.36% |
3-Year CAGR | -8.94% | 10.68% | 14.52% |
5-Year CAGR | 5.28% | 6.28% | 20.24% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the AARTI PHARMALABS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of AARTI PHARMALABS the stake stands at 46.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of AARTI PHARMALABS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
AARTI PHARMALABS paid Rs 2.0, and its dividend payout ratio stood at 9.4%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of AARTI PHARMALABS.
For a sector overview, read our pharmaceuticals sector report.
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.